Fundraising FoxYorkville Advisors
Institutional investorMountainside · 6 people tracked
Also known as YORKVILLE ADVISORS GLOBAL, LP
Find your way into Yorkville Advisors
Sign up to see every warm intro you have to Yorkville Advisors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Yorkville Advisors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Yorkville Advisors specializes in flexible debt and equity financing for both public and private companies globally. The firm tailors innovative investment strategies across a range of sectors, structuring capital arrangements designed to align with each client's vision and operational needs while supporting business growth and long-term success. Its stated values center on integrity, innovation, and collaboration with clients.
Source: firm website, verified Oct 13, 2026.
Team · 6 people
from the firm's website & public directories
Founded Yorkville in January 2001 to operate as an investment manager focused on principal investing, targeting smaller public companies.
Michael Rosselli is a Partner at Yorkville Advisors, a global investment manager that provides specialty financing to micro and small cap companies. He identifies investment opportunities and structures capital investment transactions on behalf of the fund's investors.
Troy Rillo is Managing Partner at Yorkville Advisors Global, LP, a SEC-registered investment advisor to private investment funds, and also serves as Chairman of Yorkville Securities, a broker-dealer, and as a Partner of Yorkville America. He has over 20 years of experience as a hedge fund and private equity manager and previously worked as a corporate and securities partner at the law firm K&L Gates LLP. Rillo earned a B.S. in Finance and a J.D. from the University of Florida and is admitted to practice law in New Jersey and Florida.
What they invest in
from 14 of 15 portfolio companiesHealthtech ×8Biotech ×7AI & Machine Learning ×4Advanced Manufacturing ×3Medical Devices ×2New Materials ×2Cleantech ×1Cybersecurity ×1
HQs:United States×13
Investments · 15 tracked
founders shown can be your intro pathBy year:2026 · 42025 · 12023 · 12020 · 17 dated
Abpro develops multispecific antibody therapeutics using proprietary discovery and engineering platforms, with lead programs targeting immuno-oncology, ophthalmology, and infectious disease; its advanced TetraBi antibody candidates ABP-102 (a T-cell engager for HER2+ solid tumors in partnership with Celltrion) and ABP-201 (targeting vascular disease in the eye through a territorial partnership with Abpro Bio) are designed to provide improved efficacy and safety profiles compared to existing treatments.
BiotechWoburn, US
Eugene Chan(Director)Ian Chan(Executive Officer, Director)Kevin Comerford(Executive Officer)Miles Suk(Chief Executive Officer and Chairman of the Board)Robert Markelewicz(Chief Medical Officer)in
BoardBenjamin Ha(Director)
Aptevo Therapeutics is a clinical-stage biotechnology company developing bispecific and trispecific immunotherapies to treat cancer.
BiotechHealthtechSeattle, US
Marvin L. White(Executive Officer, Director)inDaphne Taylor(Executive Officer)Jeffrey G. Lamothe(Executive Vice President and Chief Operating Officer)
BoardJohn E Niederhuber(Director)Daniel J Abdun-Nabi(Director)Grady Grant III(Director)
Co-investorsHEALTHCARE ROYALTY PARTNERS
CytoDyn is a biopharmaceutical company conducting clinical trials, including a Phase 2 colorectal cancer trial.
BiotechDigital HealthHealthtechMedical DevicesVancouver, US
Robert E. Hoffman(Executive Officer)inJacob P. Lalezari(Executive Officer)Tyler Blok(Executive Officer)inRyan M. Dunlap(Director)inMichael D. Mulholland(Executive Officer)inNadar Z. Pourhassan(Executive Officer, Director)
Evolution Metals & Technologies is a US-controlled manufacturer of certified rare earth magnets, producing bonded and sintered magnets at commercial scale in South Korea using NdPr metal sourced from outside China.
Advanced ManufacturingHardwareNew MaterialsMiami, US
Christopher Clower(Executive Officer)inSuk Jin Moon(Executive Officer)David Wilcox(Executive Officer, Director)John Arrastia(Executive Officer)Andrew F. Knaggs(Executive Officer)inFrank Moon(Chief Executive Officer)
Nakamoto Inc. operates a portfolio of Bitcoin-native companies, holding Bitcoin as a treasury asset and making minority investments in digital-asset businesses, while also operating a patient-focused healthcare practice that provides evidence-based medical services including pain management, addiction treatment, and telemedicine options.
HealthtechSalt Lake City, US
Tim Pickett(Chief Medical Officer and Director)inJared Barrera(Executive Officer)inAdam Cox(Executive Officer, Director)inDavid Bailey(Chief Executive Officer, Chairman)inTeresa Gendron(Chief Financial Officer)Amanda Fabiano(Chief Operating Officer)
Co-investorsACTAI VenturesArrington CapitalOff the Chain Capital
Nomadar is a sports company that combines athletics with technology and artificial intelligence, offering events, products, and services including a High Performance Training Program and a multipurpose technology center.
AI & Machine LearningEdTechSports TechMarshall, US
Rafael Contreras(Executive Officer, Director)Carlos Lacave(Executive Officer)inJoaquin Martin(Executive Officer)inIvan Contreras(Executive Officer)
BoardPeter Moore(Director)Manuel Vizcaino(Director)
NW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy.
BiotechHealthtechBethesda, US
Alton L. Boynton(Co-founder & Chief Scientific Officer)Marnix Bosch(Executive Officer)inLeslie Goldman(Executive Officer)Linda Powers(Executive Officer, Director)in
BoardNavid Malik(Director)Jerry Jasinowski(Director)
Co-investorsVedanta Capital
OneMedNet provides de-identified, regulatory-grade real-world data (RWD), including longitudinal clinical and imaging patient records, and AI-driven data masking that strips PII and HIPAA-sensitive details.
AI & Machine LearningData & InfrastructureHealthtechEden Prairie, US
Jeffrey Yu(Executive Officer, Director)inAaron Green(Executive Officer, Director)inLisa Embree(Executive Officer)inTHOMAS HIATT(Director)JERRY HIATT(Executive Officer, Director)CHRISTOPHER HANNA(Executive Officer, Director)
PDS Biotech develops T cell activating immunotherapies for cancer and infectious disease vaccines in clinical stages.
BiotechHealthtechNorth Brunswick, US
Frank K. Bedu-Addo(Executive Officer)inFrank Bedu-Addo(President, Chief Executive Officer, Principal Executive Officer and Director)inGregory L. Conn(Chief Scientific Officer)Kirk Shepard(Chief Medical Officer)inLars Boesgaard(Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer)inStephan Toutain(Chief Operating Officer)in
Co-investorsElevate VenturesEMV Capital
Medicus Pharma is a biotech company that identifies, acquires, and advances clinical-stage therapeutic assets through development and commercialization.
BiotechHealthtechToronto, US
Carolyn Bonner(President)inEdward Brennan(Chief Medical Officer)Raza Bokhari(Chairman and Chief Executive Officer)inErica Monaco(Chief Operating Officer)inJames Quinlan(Chief Financial Officer)
BoardRobert J. Ciaruffoli(Director)
The Metals Company is developing polymetallic nodule resources containing base metals such as nickel, cobalt, copper and manganese for use in batteries, energy transition infrastructure, defense, manufacturing and construction.
CleantechEnergyNew Materials
Gerard Barron(Founder)in
Co-investorsEthos VC
Predictive Oncology develops drug discovery solutions for biopharma companies that combine artificial intelligence with a proprietary biobank of over 150,000 tumor samples to accelerate oncology drug development and improve therapeutic outcomes for cancer patients.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechHealthtechMedical DevicesPittsburgh, US
Josh Blacher(Executive Officer)inRaymond Vennare(Executive Officer, Director)inCarl I Schwartz(Executive Officer, Director, Promoter)Bob Myers(Executive Officer)inJoshua Kornberg(Executive Officer, Director)David Johnson(Executive Officer)in
Co-investorsBain Capital Ventures
Valo.ai provides tools for Salesforce stakeholders to manage security risks, reduce costs and complexity, and improve administrative efficiency.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaS
Jari Salomaa(CEO and Co-founder)inMika Ståhlberg(CTO and Co-founder)in
Co-investorsInventureInventureSpintop Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 9
9 IPOsAbproOTC: ABPOAptevo TherapeuticsNASDAQ: APVOCytoDynOTC: CYDYEvolution Metals & TechnologiesNASDAQ: EMATKindly MDNASDAQ: NAKANomadarNASDAQ: NOMANorthwest BiotherapeuticsOTC: NWBOOneMedNetNASDAQ: ONMDPDS Biotechnology Corp.NASDAQ: PDSB
Portfolio news
latest coverage across their companies
OneMedNet · cryptoslate.com · Aug 17, 2026
Nomadar · stocktitan.net · Aug 12, 2026
Medicus Pharma · stocktitan.net · May 28, 2026
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Nov 2024
Disclosed stake · filed Nov 2024
Disclosed stake · filed Nov 2024
Disclosed stake · filed Nov 2024
Disclosed stake · filed Nov 2024
Disclosed stake · filed Nov 2024
Disclosed stake · filed Nov 2024
Disclosed stake · filed Nov 2024
Disclosed stake · filed Nov 2024
Disclosed stake · filed Sep 2024
Disclosed stake · filed Sep 2024
Disclosed stake · filed Jun 2024
2 insider ownership filings (Forms 3/4/5)
at Texas Ventures Acquisition III Corp (TVA)
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Yorkville Advisors made?
- Yorkville Advisors has 15 tracked investments, 9 of which have exited, including 5 dated in the last 24 months.
- What sectors does Yorkville Advisors focus on?
- Yorkville Advisors focuses on Crypto & Web3, Sector Agnostic.
- Where is Yorkville Advisors located?
- Yorkville Advisors is headquartered in Mountainside, US.
Images
Similar investors
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.